These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 39125777)

  • 1. Comparison of Natural Killer Cells Differentiated from Various Pluripotent Stem Cells.
    Han J; Son H; Jung D; Kim KY; Jin C; Hwang H; Kang SS; Mitalipov S; An HJ; Lee Y; Kang E
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56
    Euchner J; Sprissler J; Cathomen T; Fürst D; Schrezenmeier H; Debatin KM; Schwarz K; Felgentreff K
    Front Immunol; 2021; 12():640672. PubMed ID: 34017328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cells.
    Ueda T; Kumagai A; Iriguchi S; Yasui Y; Miyasaka T; Nakagoshi K; Nakane K; Saito K; Takahashi M; Sasaki A; Yoshida S; Takasu N; Seno H; Uemura Y; Tamada K; Nakatsura T; Kaneko S
    Cancer Sci; 2020 May; 111(5):1478-1490. PubMed ID: 32133731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Umbilical Cord Blood and iPSC-Derived Natural Killer Cells Demonstrate Key Differences in Cytotoxic Activity and KIR Profiles.
    Goldenson BH; Zhu H; Wang YM; Heragu N; Bernareggi D; Ruiz-Cisneros A; Bahena A; Ask EH; Hoel HJ; Malmberg KJ; Kaufman DS
    Front Immunol; 2020; 11():561553. PubMed ID: 33178188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of "Off-the-Shelf" Natural Killer Cells from Peripheral Blood Cell-Derived Induced Pluripotent Stem Cells.
    Zeng J; Tang SY; Toh LL; Wang S
    Stem Cell Reports; 2017 Dec; 9(6):1796-1812. PubMed ID: 29173894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of individualized immunocompatible endothelial cells from HLA-I-matched human pluripotent stem cells.
    Song C; Wang L; Li Q; Liao B; Qiao W; Li Q; Dong N; Li L
    Stem Cell Res Ther; 2022 Feb; 13(1):48. PubMed ID: 35109922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted integration of EpCAM-specific CAR in human induced pluripotent stem cells and their differentiation into NK cells.
    Tang SY; Zha S; Du Z; Zeng J; Zhu D; Luo Y; Wang S
    Stem Cell Res Ther; 2021 Nov; 12(1):580. PubMed ID: 34802459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Improved Method to Produce Clinical-Scale Natural Killer Cells from Human Pluripotent Stem Cells.
    Zhu H; Kaufman DS
    Methods Mol Biol; 2019; 2048():107-119. PubMed ID: 31396935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential role of natural killer group 2D in recognition and cytotoxicity of hepatocyte-like cells derived from embryonic stem cells and induced pluripotent stem cells.
    Cisneros T; Dillard DW; Qu X; Arredondo-Guerrero J; Castro M; Schaffert S; Martin R; Esquivel CO; Krams SM; Martinez OM
    Am J Transplant; 2019 Jun; 19(6):1652-1662. PubMed ID: 30549427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. iPSC-Derived Natural Killer Cells for Cancer Immunotherapy.
    Karagiannis P; Kim SI
    Mol Cells; 2021 Aug; 44(8):541-548. PubMed ID: 34373366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity.
    Li Y; Hermanson DL; Moriarity BS; Kaufman DS
    Cell Stem Cell; 2018 Aug; 23(2):181-192.e5. PubMed ID: 30082067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of human pluripotent stem cell-derived natural killer cells for immunotherapy under chemically defined conditions.
    Matsubara H; Niwa A; Nakahata T; Saito MK
    Biochem Biophys Res Commun; 2019 Jul; 515(1):1-8. PubMed ID: 30948156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells.
    Saetersmoen ML; Hammer Q; Valamehr B; Kaufman DS; Malmberg KJ
    Semin Immunopathol; 2019 Jan; 41(1):59-68. PubMed ID: 30361801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strong capacity of differentiated PD-L1 CAR-modified UCB-CD34
    Ghaedrahmati F; Akbari V; Seyedhosseini-Ghaheh H; Esmaeil N
    Stem Cell Res Ther; 2024 Aug; 15(1):257. PubMed ID: 39135206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy.
    Spanholtz J; Tordoir M; Eissens D; Preijers F; van der Meer A; Joosten I; Schaap N; de Witte TM; Dolstra H
    PLoS One; 2010 Feb; 5(2):e9221. PubMed ID: 20169160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced pluripotent stem cell-derived natural killer cells gene-modified to express chimeric antigen receptor-targeting solid tumors.
    Ueda T; Kaneko S
    Int J Hematol; 2021 Nov; 114(5):572-579. PubMed ID: 32705572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of universal natural killer cells from a cryopreserved cord blood mononuclear cell-derived induced pluripotent stem cell library.
    Du W; Cui L; Zhang J; Zhang H; Liu R; Yang W; Zhang Y
    FEBS Open Bio; 2022 Oct; 12(10):1771-1781. PubMed ID: 35747945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy.
    Knorr DA; Ni Z; Hermanson D; Hexum MK; Bendzick L; Cooper LJ; Lee DA; Kaufman DS
    Stem Cells Transl Med; 2013 Apr; 2(4):274-83. PubMed ID: 23515118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of innate immune cells from human pluripotent stem cells.
    Bernareggi D; Pouyanfard S; Kaufman DS
    Exp Hematol; 2019 Mar; 71():13-23. PubMed ID: 30611869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and Functional Characterization of Anti-CD19 Chimeric Antigen Receptor-Natural Killer Cells from Human Induced Pluripotent Stem Cells.
    Klaihmon P; Kang X; Issaragrisil S; Luanpitpong S
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.